Tradjenta Available for Type 2 Diabetes

TRADJENTA (linagliptin) 5mg tablets by Boehringer Ingelheim and Eli Lilly
TRADJENTA (linagliptin) 5mg tablets by Boehringer Ingelheim and Eli Lilly
Tradjenta (linagliptin) has been made available by Boehringer Ingelheim and Eli Lilly as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.

Tradjenta, a dipeptidyl peptidase-4 (DPP-4) inhibitor, is available in a 5mg dosage strength tablet.

For more information call (800) 542-6257 or visit www.tradjenta.com.